One of the most frequent alterations is FGFR1 gene amplification, notably occurring in ovarian cancer, head and neck cancer, urothelial cancer and lung cancer, with a frequency of 9 to 28% [45,46]. This evidence concerns the gene FGFR1 and lung carcinoma.